Market Place
Sourcing Support
All News #Library
Others
AstraZeneca returns to China`s CSPC for $18.5B obesity dea
31 Jan 2026 //
PRESS RELEASE
AstraZeneca Puts $2B On The Line for Preclinical Heart Disease Drug
08 Oct 2024 //
BIOSPACE
Voluntary Announcement Olaparib Tablets Obtains Drug Registration Approval
03 Jun 2024 //
PRESS RELEASE
HanAll`s Licensed Partner Enters Agreement with CSPC for Batoclimab
11 Oct 2022 //
PRNEWSWIRE
Elevation Oncology Expands Pipeline through Exclusive Licensing of EO-3021
28 Jul 2022 //
PRNEWSWIRE
IND Approved for Pivotal Clinical Study of HER2 Bispecific Antibody KN026
05 Jan 2022 //
ASIAONE
China Pharmaceutical Ltd. Has Obtained Multiple Certifications for Its Masks
21 Sep 2020 //
PRNASIA
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
04 Jun 2019 //
FIERCE PHARMA
China`s generic drug makers struggle to survive bulk-buy policy onslaught
02 Jan 2019 //
JAPAN TIMES
I-Mab, CSPC Pharma Announce Strategic Partnership for GLP-1 Fc Program
18 Dec 2018 //
PR NEWSWIRE
CSPC Pharma, Verastem sign license agreement for cancer treatment
05 Oct 2018 //
BIOSPECTRUM
CSPC Pharma, Verastem Sign Exclusive License Agreement for COPIKTRA™ (duvelisib) in China
25 Sep 2018 //
BUSINESSWIRE
Cancer, hepatitis treatments set for boost as China overhauls drugs list
26 Jan 2017 //
REUTERS
GlaxoSmithKline Seeks U.S. Approval for Triple Lung Drug
22 Nov 2016 //
REUTERS
China`s CSPC out-licenses unspecified generic oncology drug to Watson in $106M deal
05 May 2016 //
FIERCE ASIA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.